Home » Stocks » Aethlon Medical

Aethlon Medical, Inc. (AEMD)

Stock Price: $2.03 USD 0.09 (4.64%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed
After-hours: $1.97 -0.06 (-2.96%) Aug 3, 7:19 PM

Stock Price Chart

Key Info

Market Cap 24.50M
Revenue (ttm) 650,187
Net Income (ttm) -6.37M
Shares Out 12.07M
EPS (ttm) -1.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $2.03
Previous Close $1.94
Change ($) 0.09
Change (%) 4.64%
Day's Open 1.91
Day's Range 1.91 - 2.05
Day's Volume 247,008
52-Week Range 0.76 - 6.89

More Stats

Market Cap 24.50M
Enterprise Value 14.89M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 12.07M
Float 11.79M
EPS (basic) -1.87
EPS (diluted) -1.87
FCF / Share -1.57
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 715,684
Short Ratio 0.10
Short % of Float 5.29%
Beta 0.73
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 37.69
PB Ratio 2.51
Revenue 650,187
Operating Income -5.93M
Net Income -6.37M
Free Cash Flow -5.35M
Net Cash 9.62M
Net Cash / Share 0.80
Gross Margin 100.00%
Operating Margin -912.04%
Profit Margin -980.30%
FCF Margin -822.73%
ROA -51.08%
ROE -110.22%
ROIC 1,330.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$45.00*
Low
45.0
Current: $2.03
High
45.0
Target: 45.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.650.230.150.390.890.761.621.231.36-
Revenue Growth183.15%53.47%-61.84%-55.78%16.28%-53.05%32.01%-9.53%--
Gross Profit0.650.230.150.390.890.761.621.231.36-
Operating Income-5.93-6.00-4.83-6.10-4.38-3.99-3.06-3.58-3.11-4.56
Net Income-6.37-6.19-5.68-7.28-4.87-6.80-13.36-4.89-8.11-5.71
Shares Outstanding3.411.210.820.520.490.370.260.200.140.09
Earnings Per Share-1.87-5.13-6.90-14.10-9.90-18.30-51.60-22.50-60.00-60.00
Operating Cash Flow-5.20-4.29-3.91-3.51-4.33-5.05-2.14-2.10-1.84-1.97
Capital Expenditures-0.15--0.02-0.02-0.01--0.10---
Free Cash Flow-5.35-4.29-3.94-3.52-4.34-5.05-2.24-2.10-1.84-1.97
Cash & Equivalents9.623.846.991.572.150.861.250.130.150.22
Total Debt-0.960.840.520.500.162.532.693.662.37
Net Cash / Debt9.622.886.151.061.650.70-1.28-2.56-3.51-2.15
Assets10.394.127.351.732.531.381.700.500.840.57
Liabilities1.111.821.321.131.030.7316.439.6410.136.54
Book Value9.412.436.130.681.550.62-14.95-9.14-9.30-5.98
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aethlon Medical, Inc.
Country United States
Employees 8
CEO Timothy C. Rodell

Stock Information

Ticker Symbol AEMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AEMD

Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.